Document is current
Any future updates will be listed below
-
Authors
Yuan, Chengxiang
Chakraborty, Smarajit
Chitta, Krishna Kanth
Subramanian, Subha
Lim, Tau En
Han, Weiping
Bhanu Prakash, K. N.
Sugii, Shigeki http://orcid.org/0000-0002-2537-9534
-
Funding
Funding for this research was provided by:
Agency for Science, Technology and Research
- License Information
-
More Information
Article History
Received: 26 September 2018
Revised: 25 December 2018
Accepted: 7 January 2019
First Online: 22 January 2019
Ethics approval and consent to participate
: Use of human patients-derived cells was conducted with informed consent obtained for each subject, approved by the National Healthcare Group Domain Specific Review Board, Singapore, and performed in accordance with its relevant regulations.
: Not applicable
: S. Sugii is a co-founder and shareholder of Celligenics Pte. Ltd., of which this study is not under any financial or scientific influence. Other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
